Close Menu

newborn screening

The researchers — who previously demonstrated that PCR-based CMV testing of commonly collected dried blood spots had low sensitivity compared to rapid culture — have made a strong case for saliva-based testing as a more promising tool to screen newborns for CMV, a leading cause of hearing loss in children.

Luminex will be going after a piece of the newborn screening market, estimated to be a $100 million-plus opportunity, with a new assay slated for an initial launch in Europe later this year.

Two sets of grants will support genome-based research into diseases for which newborns are screened.

It remains to be seen whether a market for PCR-based fragile X population screening will soon develop, since mandating newborn testing may be highly dependent on the development of a difference-making therapeutic; and carrier screening will likely continue to rely on a case-by-case cost-benefit analysis.

The Research Initiative in Newborn Screening program will give $2 million in 2011 to support studies of diseases that could potentially be addressed with more and enhanced newborn screening tools.

The sensitivity of real-time PCR-based testing of dried blood spots is too low to use the method as a routine test for CMV infection in newborns. Despite this, PCR testing of other bodily fluids such as saliva still holds promise for such a test.

Genetic Alliance, UTHSC, and others will create a newborn screening data center and resource using a $3.8 million grant.

Pages

NPR says the explosion and fire earlier this week at a Russian lab that stores dangerous pathogens revives the question of whether such samples should be kept.

According to Wired, Nebula Genomics is providing a way for people to get their genomes sequenced anonymously.

A 26-year-old woman tells Cosmopolitan about learning her APOE status at a young age.

In Science journals this week: a functional genomic screen uncovers drug combination that increases KRAS inhibitor efficacy in aggressive lung cancer, and more.